Ligand validation:2AC1

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 2AC1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2AC1_NAG_A_770	4%	65%	0.308	0.685	0.59	0.74	-	1	1	0	100%	1
2XQR_NAG_A_3000	67%	58%	0.123	0.931	0.5	1.09	-	2	0	0	100%	1
2OXB_NAG_A_660	52%	58%	0.156	0.915	0.58	1	-	-	2	0	100%	1
2QQV_NAG_A_770	19%	60%	0.282	0.878	0.59	0.93	-	1	0	0	100%	1
2QQW_NAG_A_770	16%	54%	0.315	0.883	0.46	1.29	-	2	0	0	100%	1
2QQU_NAG_A_770	7%	50%	0.392	0.843	0.61	1.32	-	2	0	0	100%	1
7DDF_NAG_B_401	100%	87%	0.02	0.992	0.21	0.47	-	-	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1
5O5D_NAG_B_501	100%	64%	0.02	0.995	0.38	0.97	-	1	0	0	100%	1
5LDS_NAG_A_1016	100%	70%	0.021	0.995	0.52	0.64	-	-	2	0	100%	1
5F9W_NAG_G_505	100%	86%	0.023	0.994	0.21	0.5	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.